STM Journals Peer-reviewed research from Consortium e-Learning Network

International Journal of Molecular Biotechnological Research Original Research

In silico Molecular Docking Analysis of Stephania glabra phytocompounds Targeting Thymidylate Kinase for potential Antituberculosis Activity

  1. Sandeep Chandaragi Bionome (CRO)

Abstract

Tuberculosis (TB) is an infectious disease caused by the bacteria Mycobacterium tuberculosis. It mainly affects the lungs and spreads through the air when a person with active TB in their lungs coughs, sneezes, or spits. This study investigates several bioactive compounds derived from plants to forecast how effective plant-based ligands will be at preventing tuberculosis. The purpose of the study was to use computational techniques to assess the effectiveness of several phytochemicals against the Mycobacterium. Molecular docking was systematically carried out using the virtual screening software PyRx. The top 5 phytocompounds from Stephania glabra were chosen among them to test their compatibility with the thymidylate protein 5NR7, using the ADMET filters, the ligands pharmacological evaluation was performed. The phytocompounds Roemerine, Stepholidine, Tetrahydropalmatine, Rotundine, Corydalmine from the plant Stephania glabra were discovered to be the most potent antagonist for the protein Thymidylate kinase. All of the bioactive chemicals could be considered as deserving candidates for the suppression of tuberculosis due to their strong affinity for the protein. Among the top ligand the phytoconstituent Roemerine demonstrated better binding affinity with target.

Keywords

References (76)

  1. Lam A, Prabhu R, Gross CM, Riesenberg LA, Singh V, Aggarwal S. Role of
  2. apoptosis and autophagy in tuberculosis. Am J Physiol Lung Cell Mol Physiol.
  3. 2017;313(2):L218–29.
  4. Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis.
  5. Nat Rev Dis Primers. 2016;2:16076.
  6. Raja A. Immunology of tuberculosis. Indian J Med Res. 2004;120(4):213–32.
  7. Mortaz E, Adcock IM, Tabarsi P, Masjedi MR, Mansouri D, Velayati AA, et al.
  8. Interaction of pattern recognition receptors with Mycobacterium tuberculosis. J Clin
  9. Immunol. 2015;35(1):1–10.
  10. Jayanthi K, Azam MA. Thymidylate kinase inhibitors as antibacterial agents: A
  11. review. Appl Biochem Microbiol. 2023;59(3):250–66.
  12. Cui WS, Shin Y, Luo J, Tian H, Cui DY. Thymidylate kinase: an old topic brings new
  13. perspectives. Curr Med Chem. 2013;20(10):1281–92.
  14. Sukumar S, Krishnan A, Khan MKA. Protein kinases as antituberculosis targets: the
  15. case of thymidylate kinases. Front Biosci (Landmark Ed). 2020;25:1042–55.
  16. Owono Owono LC, Keita M, Megnassan E, Frecer V, Miertus S. Design of thymidine
  17. analogues targeting thymidylate kinase of Mycobacterium tuberculosis. Tuberc Res
  18. Treat. 2013;2013:670836.
  19. Shahab M, Danial M, Duan X, Khan T, Liang C, Gao H, et al. Machine learning-
  20. based drug design for identification of thymidylate kinase inhibitors as potential anti-
  21. Mycobacterium tuberculosis. J Biomol Struct Dyn. 2023.
  22. doi:10.1080/07391102.2023.2216278.
  23. Song L, Merceron R, Hulpia F, Lucía A, Gracia B, Jian Y, et al. Structure-aided
  24. optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors. Eur J
  25. Med Chem. 2021;218:113784.
  26. Tuang KL, Min HM, Sein MM. Extraction, isolation, antimicrobial study and
  27. structural elucidation of a pure compound isolated from the tuber of Stephania glabra
  28. (Roxb.) Miers. [Journal name and volume/issue/page not provided—please complete.]
  29. Semwal DK, Semwal RB. Efficacy and safety of Stephania glabra: an alkaloid-rich
  30. traditional medicinal plant. Nat Prod Res. 2014;29(5):396–410.
  31. Duke JA. Handbook of phytochemical constituents of GRAS herbs and other
  32. economic plants. Boca Raton (FL): CRC Press; 1992.
  33. Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem 2025 update.
  34. Nucleic Acids Res. 2025;53(D1):D1516–25.
  35. Song L, Merceron R, Gracia B, Quintana AL, Risseeuw MDP, Hulpia F, et al. J Med
  36. Chem. 2018;61(7):2753–75.
  37. Jejurikar BL, Rohane SH. Drug designing in discovery studio. Asian J Res Chem.
  38. 2021;14(2):135–8.
  39. Zhou AQ, O’Hern CS, Regan L. Revisiting the Ramachandran plot from a new angle.
  40. Protein Sci. 2011;20(7):1166–71.
  41. Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate
  42. pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small
  43. molecules. Sci Rep. 2017;7:42717.
  44. Yang H, Lou C, Sun L, Li J, Cai Y, Wang Z, et al. ADMETsar 2.0: web-service for
  45. prediction and optimization of chemical ADMET properties. Bioinformatics.
  46. 2019;35(6):1067–9.
  47. Kondapuram SK, Sarvagalla S, Coumar MS. Docking-based virtual screening using
  48. PyRx tool: autophagy target Vps34 as a case study. In: Molecular Docking for
  49. Computer-Aided Drug Design. Amsterdam: Elsevier Inc.; 2021. p. 463–77.
  50. Tobin EH, Tristram D. Tuberculosis overview. [Updated 2024 Dec 22]. In: StatPearls
  51. [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from:
  52. https://www.ncbi.nlm.nih.gov/books/NBK441916/
  53. Warner DF, Koch A, Mizrahi V. Diversity and disease pathogenesis in Mycobacterium
  54. tuberculosis. Trends Microbiol. 2015;23(1):14–21.
  55. Tiberi S, du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, et al. Tuberculosis:
  56. progress and advances in development of new drugs, treatment regimens, and host-
  57. directed therapies. Lancet Infect Dis. 2018;18(7):e183–98.
  58. Delogu G, Sali M, Fadda G. The biology of Mycobacterium tuberculosis infection.
  59. Mediterr J Hematol Infect Dis. 2013;5(1):e2013070.
  60. Lei B, Wei CJ, Tu SC. Action mechanism of antitubercular isoniazid: activation by
  61. Mycobacterium tuberculosis KatG, isolation, and characterization of InhA inhibitor. J
  62. Biol Chem. 2000;275(4):2520–6.
  63. Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, et al.
  64. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell.
  65. 2001;104(6):901–12.
  66. Jong AY, Kuo CL, Campbell JL. The CDC8 gene of yeast encodes thymidylate
  67. kinase. J Biol Chem. 1984;259(17):11052–9.
  68. Sclafani RA, Fangman WL. Yeast gene CDC8 encodes thymidylate kinase and is
  69. complemented by herpes thymidine kinase gene TK. Proc Natl Acad Sci U S A.
  70. 1984;81(18):5821–5.
  71. Ferguson FM, Gray NS. Kinase inhibitors: the road ahead. Nat Rev Drug Discov.
  72. 2018;17(7):535–77.
  73. Xu C, Yang S, Jiang Z, Chen T. Protein kinase inhibitors as potential antimicrobial
  74. drugs against tuberculosis, malaria, and HIV. Curr Pharm Des. 2017;23(29):4369–89.
  75. Qi B, Li L, Huang R. Alkaloid variations within the genus Stephania
  76. (Menispermaceae) in China. Heliyon. 2023;9(5):e16344.